Muntañola, Ana; Arguiñano-Pérez, José María; Dávila, Julio; González de Villambrosía, Sonia; Carpio, Cecilia; Jiménez-Ubieto, Ana; Salar Silvestre, Antonio; GELTAMO Group
(Wiley, 2023)
Although rituximab is generally well-tolerated, infusion-related reactions (IRRs) are common with the initial dose when administered intravenously according to standard recommendations. To prevent IRRs, premedication and ...